Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Glucose-Coated Superparamagnetic Iron Oxide Nanoparticles Prepared By Metal Vapour Synthesis Are Electively Internalized In A Pancreatic Adenocarcinoma Cell Line Expressing GLUT1 Transporter

D. Barbaro, L. Di Bari, V. Gandin, C. Evangelisti, G. Vitulli, E. Schiavi, C. Marzano, A. Ferretti, P. Salvadori
Published 2015 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Iron oxide nanoparticles (IONP) can have a variety of biomedical applications due to their visualization properties through Magnetic Resonance Imaging (MRI) and heating with radio frequency or alternating magnetic fields. In the oncological field, coating IONP with organic compounds to provide specific features and to achieve the ability of binding specific molecular targets appears to be very promising. To take advantage of the high avidity of tumor cells for glucose, we report the development of very small glucose-coated IONP (glc-IONP) by employing an innovative technique, Metal Vapor Synthesis (MVS). Moreover, we tested the internalization of our gl-IONP on a tumor line, BxPC3, over-expressing GLUT 1 transporter. Both glc-IONP and polyvinylpyrrolidone-IONP (PVP-IONP), as control, were prepared with MVS and were tested on BxPC3 at various concentrations. To evaluate the role of GLUT-1 transporter, we also investigated the effect of adding a polyclonal anti-GLUT1 antibody. After proper treatment, the iron value was assessed by atomic absorption spectrometer, reported in mcg/L and expressed in mg of protein. Our IONP prepared with MVS were very small and homogeneously distributed in a narrow range (1.75-3.75 nm) with an average size of 2.7 nm and were super-paramagnetic. Glc-IONP were internalized by BxPC3 cells in a larger amount than PVP-IONP. After 6h of treatment with 50 mcg/mL of IONPs, the content of Fe was 1.5 times higher in glc-IONP-treated cells compared with PVP-IONP-treated cells. After 1h pre-treatment with anti-GLUT1, a reduction of 41% cellular accumulation of glc-IONP was observed. Conversely, the uptake of PVP-IONPs was reduced only by 14% with antibody pretreatment. In conclusion, MVS allowed us to prepare small, homogeneous, super-paramagnetic glc-IONP, which are electively internalized by a tumor line over-expressing GLUT1. Our glc-IONP appear to have many requisites for in vivo use.
This paper references
10.1021/LA701100R
Cellular level loading and heating of superparamagnetic iron oxide nanoparticles.
V. Kalambur (2007)
10.1073/PNAS.0503879102
Mechanics of receptor-mediated endocytosis.
H. Gao (2005)
10.1083/jcb.200407078
Ultrastructural identification of uncoated caveolin-independent early endocytic vehicles
M. Kirkham (2005)
10.1007/s11060-005-9059-z
The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma
A. Jordan (2005)
10.1021/cr068445e
Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications.
S. Laurent (2008)
10.1155/2014/625095
Current Opportunities and Challenges of Magnetic Resonance Spectroscopy, Positron Emission Tomography, and Mass Spectrometry Imaging for Mapping Cancer Metabolism In Vivo
G. Lin (2014)
Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges.Expert Opin Drug Deliv
S Laurent (2014)
Metal Vapor-Derived Nanostructure Catalysts in Fine Chemistry: the Role Played by Particles Size in the Catalytic Activity and Selectivity The Issue of Size-Control
G Vitulli (2007)
10.1002/9783527616077.CH6
The Chemistry of Transition Metal Colloids
J. Bradley (2007)
10.1007/s11095-011-0653-9
Preparation, Characterization of 2-Deoxy-D-Glucose Functionalized Dimercaptosuccinic Acid-Coated Maghemite Nanoparticles for Targeting Tumor Cells
F. Xiong (2011)
10.1016/B978-044453057-8.50034-9
CHAPTER 32 – Metal Vapor-Derived Nanostructured Catalysts in Fine Chemistry: The Role Played by Particle Size in the Catalytic Activity and Selectivity
G. Vitulli (2008)
10.1158/0008-5472.CAN-06-1501
Cancer's molecular sweet tooth and the Warburg effect.
J. Kim (2006)
10.2217/17435889.2.1.23
Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications.
A. Gupta (2007)
10.1371/journal.pone.0081043
Glucose-Coated Gold Nanoparticles Transfer across Human Brain Endothelium and Enter Astrocytes In Vitro
R. Gromnicova (2013)
10.1073/pnas.1000386107
Molecular MRI for sensitive and specific detection of lung metastases
R. Branca (2010)
10.1186/1477-3155-10-35
ATP driven clathrin dependent entry of carbon nanospheres prefer cells with glucose receptors
R. Selvi (2012)
10.1016/b978-0-444-53057-8.x5001-6
Metal nanoclusters in catalysis and materials science
B. Corain (2013)
10.1097/01.rli.0000209601.15533.5a
Local Arterial Infusion of Superparamagnetic Iron Oxide Particles in Hepatocellular Carcinoma: A Feasibility and 3.0 T MRI Study
O. Dudeck (2006)
From theory to applications
F. Ulaby (1986)
10.1016/s1351-4180(08)70385-4
Metal nanoclusters in catalysis and materials science : the issue of size control
B. Corain (2008)
10.1038/nbt1340
Renal clearance of quantum dots
H. Choi (2007)
10.1166/JNN.2014.8747
Biophysicochemical perspective of nanoparticle compatibility: a critically ignored parameter in nanomedicine.
S. Hassan (2014)
10.1073/PNAS.94.13.6658
c-Myc transactivation of LDH-A: implications for tumor metabolism and growth.
H. Shim (1997)
10.1080/02656730600734128
18F-FET PET for planning of thermotherapy using magnetic nanoparticles in recurrent glioblastoma
M. Plotkin (2006)
10.1016/j.bbcan.2012.12.004
Expression of glucose transporters in cancers.
L. Szablewski (2013)
Metal Vapor-Derived Nanostructure Catalysts in Fine Chemistry: the Role Played by Particles Size in the Catalytic Activity and Selectivity
G Vitulli (2007)
10.1016/j.coph.2014.08.002
Superparamagnetic iron oxide nanoparticles for MR imaging and therapy: design considerations and clinical applications.
Rongrong Jin (2014)
10.3109/02656739609027678
Cellular uptake of magnetic fluid particles and their effects on human adenocarcinoma cells exposed to AC magnetic fields in vitro.
A. Jordan (1996)
10.1016/c2009-0-21275-x
Free Atoms, Clusters, and Nanoscale Particles
K. Klabunde (1994)
10.1524/ZPCH.1995.189.PART_2.277
Clusters and Colloids — From Theory to Application
H. Mueller (1995)
10.1080/02656730601106037
Magnetic nanoparticles for interstitial thermotherapy – feasibility, tolerance and achieved temperatures
>Peter Wust (2006)
Thermotherapy and nanomedicine: between vision and reality
A. Jordan (2006)
10.1007/978-0-387-33441-7
Hyperthermia in Cancer Treatment: A Primer
G. F. Baronzio (2006)
Glucose-Coated Iron Oxide Nanoparticles Uptake in a Cancer Cell Line PLOS ONE | DOI:10.1371/journal.pone
10.3978/J.ISSN.2218-676X.2013.08.05
Externally modulated theranostic nanoparticles.
Cordula Urban (2013)
10.7150/thno.5860
Superparamagnetic Nanoparticle Clusters for Cancer Theranostics Combining Magnetic Resonance Imaging and Hyperthermia Treatment
K. Hayashi (2013)
Superparamagnetic iron oxide nanoparticles fo MR imaging and therapy: design considerations and clinical applications
R Jin (2014)
10.1002/9783527616077
Clusters and Colloids
G. Schmid (1994)
10.1007/s11060-006-9195-0
Intracranial Thermotherapy using Magnetic Nanoparticles Combined with External Beam Radiotherapy: Results of a Feasibility Study on Patients with Glioblastoma Multiforme
K. Maier-Hauff (2006)
10.1517/17425247.2014.924501
Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges
S. Laurent (2014)
10.1186/1477-3155-10-3
Synthesis and characterization of core-shell Fe3O4-gold-chitosan nanostructure
H. Salehizadeh (2012)
10.1080/02656730500158360
Clinical hyperthermia of prostate cancer using magnetic nanoparticles: Presentation of a new interstitial technique
M. Johannsen (2005)
10.1016/j.ejrad.2011.03.013
Targeting Glut1-overexpressing MDA-MB-231 cells with 2-deoxy-D-g1ucose modified SPIOs.
X. H. Shan (2012)
Clusters and colloids : from theory to applications
G. Schmid (1994)
10.1016/J.EURURO.2006.11.023
Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three-dimensional temperature distribution.
M. Johannsen (2007)



This paper is referenced by
10.1245/s10434-017-5799-1
Preoperative High Maximum Standardized Uptake Value in Association with Glucose Transporter 1 Predicts Poor Prognosis in Pancreatic Cancer
A. Chikamoto (2017)
10.1016/j.ejpb.2017.03.014
pH responsive controlled release of anti‐cancer hydrophobic drugs from sodium alginate and hydroxyapatite bi‐coated iron oxide nanoparticles
D. C. Manatunga (2017)
10.5101/nbe.v11i4.p347-350
The Role of Glucose Transporter 1 in Drug Delivery: Transporter, Receptor and/or Signaling Component
S. Mehran (2019)
10.1155/2015/624074
Molecular Imaging with MRI: Potential Application in Pancreatic Cancer
C. Chen (2015)
Developing a Silica-Coated Iron Oxide Nanovehicle for Antibody-Targeted Cancer Therapy
Zi Hui Wei (2015)
10.2217/nnm-2018-0022
Uptake mechanism of metabolic-targeted gold nanoparticles.
Tamar Dreifuss (2018)
10.1002/jat.3953
Cytotoxicity, cellular uptake and apoptotic responses in human coronary artery endothelial cells exposed to ultrasmall superparamagnetic iron oxide nanoparticles
Teresa Palacios-Hernandez (2020)
10.3390/nano9121791
Recent Advances in Magnetite Nanoparticle Functionalization for Nanomedicine
R. C. Popescu (2019)
Investigating the Radiosensitivity Effect of Dextran-coated Iron Oxide Nanoparticles on Cervical Cancerous Cells Irradiated with 6 MV Photon Beams
Hossein Mafakhei (2016)
10.1007/s11095-019-2673-9
Sugar Modification Enhances Cytotoxic Activity of PAMAM-Doxorubicin Conjugate in Glucose-Deprived MCF-7 Cells – Possible Role of GLUT1 Transporter
Krzysztof Sztandera (2019)
10.2147/IJN.S253184
Assessment of Gold-Coated Iron Oxide Nanoparticles as Negative T2 Contrast Agent in Small Animal MRI Studies
Stefania D. Iancu (2020)
10.1002/AOC.3641
Glucose‐coated superparamagnetic nanoparticle‐catalysed pyrazole synthesis in water
Naghmeh Esfandiary (2017)
10.1007/s10967-018-6282-6
Hyaluronic acid-modified [19F]FDG-conjugated magnetite nanoparticles: in vitro bioaffinities and HPLC analyses in organs
Volkan Yasakci (2018)
10.29252/ARAKMU.11.5.31
The Cytotoxicity of Dextran-coated Iron Oxide Nanoparticles on Hela and MCF-7 Cancerous Cell Lines
M. Rezaei (2017)
10.1016/j.ijpharm.2018.02.007
Nanomedicine: An effective tool in cancer therapy.
S. Aftab (2018)
10.2147/IJN.S213079
Glucose-coated Berberine Nanodrug for Glioma Therapy through Mitochondrial Pathway
Shu-bin Wang (2020)
10.13023/ETD.2016.157
PEPTIDE-FUNCTIONALIZED MAGNETIC NANOPARTICLES FOR CANCER THERAPY APPLICATIONS
Anastasia K. Hauser (2016)
of PAMAM-Doxorubicin Conjugate in Glucose-Deprived MCF-7 Cells – Possible Role of GLUT 1 Transporter
Krzysztof Sztandera (2019)
10.1007/s10876-017-1204-2
Intracellular Uptake of PEG-Funtionalized Baicalein Loaded Iron Oxide Nanoparticles Regulates Apoptotic Genes in Triple Negative Breast Cancer Cells: Mitochondrial Pathway Targeted Therapy for Breast Cancer
K. Kavithaa (2017)
10.1155/2017/3849373
Mapping Extracellular pH of Gliomas in Presence of Superparamagnetic Nanoparticles: Towards Imaging the Distribution of Drug-Containing Nanoparticles and Their Curative Effect on the Tumor Microenvironment
Samuel Maritim (2017)
Semantic Scholar Logo Some data provided by SemanticScholar